Literature DB >> 3182197

Effects of oxygen rearing on the electroretinogram and GFA-protein in the rat.

J S Penn1, L A Thum, M N Rhem, S J Dell.   

Abstract

Albino rats were maintained in 60% oxygen from birth through 14 days of age. Control rats were simultaneously maintained in room air. At the end of the exposure period some animals from both groups were prepared for electroretinography and, following this analysis, were sacrificed for histological scrutiny of retinal vasculature. The rest of the rats were removed to room air and allowed to remain for various periods of time before electroretinography and sacrifice. Some of the retinas from the latter group were analyzed for the presence of glial fibrillary acidic protein (GFAP) by immunocytochemistry. Oxygen exposed rats had a permanent reduction of the b-wave of the electroretinogram (ERG). The a-waves of the two groups were indistinguishable. Control rats showed GFAP reactivity in the retinal astrocytes at all times. The oxygen-treated rats showed positive GFAP-staining in astrocytes at all times and in Müller cells from 2 weeks post-treatment through 8 weeks post-treatment, the last time point. Immunoblot analysis confirmed that the anti-GFAP reacted with a protein having a molecular weight and solubility characteristics like those of GFAP. These results indicate that Müller cells produce GFAP in response to oxygen-rearing in newborn rats and that this production occurs in the absence of any detectable neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182197

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

Review 1.  Testing retinal toxicity of drugs in animal models using electrophysiological and morphological techniques.

Authors:  Ido Perlman
Journal:  Doc Ophthalmol       Date:  2008-11-09       Impact factor: 2.379

2.  Müller cell alterations from long-term ambient fluorescent light exposure in monkeys: light and electron microscopic, fluorescein and lipofuscin study.

Authors:  D K Berler
Journal:  Trans Am Ophthalmol Soc       Date:  1989

3.  Infliximab exerts a dose-dependent effect on retinal safety in the albino rabbit.

Authors:  Shiri Zayit-Soudry; Igor Vainer; Esther Zemel; Michael Mimouni; Melvin Rabena; Dante J Pieramici; Ido Perlman; Anat Loewenstein
Journal:  Doc Ophthalmol       Date:  2017-08-19       Impact factor: 2.379

4.  Oxygen-induced retinopathy in the rat: possible contribution of peroxidation reactions.

Authors:  J S Penn
Journal:  Doc Ophthalmol       Date:  1990-03       Impact factor: 2.379

Review 5.  Postnatal hyperoxia and the developing rat retina: beyond the obvious vasculopathy.

Authors:  A L Dorfman; S Chemtob; P Lachapelle
Journal:  Doc Ophthalmol       Date:  2009-12-10       Impact factor: 2.379

Review 6.  The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy.

Authors:  Erica L Fletcher; Laura E Downie; Kate Hatzopoulos; Kirstan A Vessey; Michelle M Ward; Chee L Chow; Michael J Pianta; Algis J Vingrys; Michael Kalloniatis; Jennifer L Wilkinson-Berka
Journal:  Doc Ophthalmol       Date:  2009-09-08       Impact factor: 2.379

7.  Corneal electrode for recording electroretinograms in rats.

Authors:  M Rosner; P Bobak; T L Lam
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

8.  Experimental oxygen-induced retinal detachment in the newborn Wistar rat.

Authors:  G Calogero; B Ricci
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

Review 9.  The effect of oxygen and light on the structure and function of the neonatal rat retina.

Authors:  A L Dorfman; S Joly; P Hardy; S Chemtob; P Lachapelle
Journal:  Doc Ophthalmol       Date:  2008-05-16       Impact factor: 2.379

10.  The effect of wavelength on glial fibrillary acidic protein immunoreactivity in laser-induced lesions in rabbit retina.

Authors:  M J Tassignon; N Stempels; J Nguyen-Legros; F De Wilde; M Brihaye
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.